| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the John Wayne Cancer Institute, Santa Monica, California.
Correspondence: Address correspondence and reprint requests to: Richard Essner, MD, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404; Fax: 310-449-5259; E-mail: essner{at}jwci.org
Background: Patients with distant melanoma metastases have median survivals of 4 to 8 months. Previous studies have demonstrated improved survival after complete resection of pulmonary and hollow viscus gastrointestinal metastases. We hypothesized that patients with metastatic disease to intra-abdominal solid organs might also benefit from complete surgical resection.
Methods: A prospectively acquired database identified patients treated for melanoma metastatic to the liver, pancreas, spleen, adrenal glands, or a combination of these from 1971 to 2000. The primary intervention was complete or incomplete surgical resection of intra-abdominal solid-organ metastases, and the main outcome measure was postoperative overall survival (OS). Disease-free survival (DFS) was a secondary outcome measure.
Results: Sixty patients underwent adrenalectomy, hepatectomy, splenectomy, or pancreatectomy. Median OS was significantly improved after complete versus incomplete resections, but median OS after complete resection was not significantly different for single-site versus synchronous multisite metastases. The 5-year survival in the group after complete resection was 24%, whereas in the incomplete resection group, there were no 5-year survivors. Median DFS after complete resection was 15 months. Of note, the 2-year DFS after complete resection was 53% for synchronous multi-site metastases versus 26% for single-site metastases.
Conclusions: In highly selected patients with melanoma metastatic to intra-abdominal solid organs, aggressive attempts at complete surgical resection may improve OS. It is important that the number of metastatic sites does not seem to affect the OS after complete resection.
Key Words: Metastatic melanoma • Hepatic • Spleen • Adrenal gland • Surgical resection
This article has been cited by other articles:
 |
|
 |
|
  F. J. Collinson, T. K. Lam, W. M. J. Bruijn, J. H. W. de Wilt, M. Lamont, J. F. Thompson, and R. F. Kefford Long-term Survival and Occasional Regression of Distant Melanoma Metastases after Adrenal Metastasectomy Ann. Surg. Oncol., June 1, 2008; 15(6): 1741 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S Mackenzie, M. J Ashby, T. Donovan, D. D Voutnis, and M. J Brown Bilateral adrenal masses: phaeochromocytoma or melanoma? J R Soc Med, March 1, 2006; 99(3): 153 - 155. [Full Text] [PDF]
|
|
|
|
|
|
F. Sellner, N. Tykalsky, M. De Santis, J. Pont, and M. Klimpfinger Solitary and Multiple Isolated Metastases of Clear Cell Renal Carcinoma to the Pancreas: An Indication for Pancreatic Surgery Ann. Surg. Oncol., January 1, 2006; 13(1): 75 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Finkelstein, J. A. Carrasquillo, J. M. Hoffman, B. Galen, P. Choyke, D. E. White, S. A. Rosenberg, and R. M. Sherry A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing Metastasectomy Ann. Surg. Oncol., August 1, 2004; 11(8): 731 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Takeuchi, C. Kuo, D. L. Morton, H.-J. Wang, and D. S. B. Hoon Expression of Differentiation Melanoma-associated Antigen Genes Is Associated with Favorable Disease Outcome in Advanced-Stage Melanomas Cancer Res., January 15, 2003; 63(2): 441 - 448. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
